European commission (ec) approves merck's capvaxive® (pneumococcal 21-valent conjugate vaccine) for prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults

Rahway, n.j.--(business wire)---- $mrk #mrk--european commission (ec) approves merck's capvaxive® for prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults.
EC Ratings Summary
EC Quant Ranking